Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-20 Exercise |
2023-11-20 12:07 pm |
N/A N/A |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
40,000 | $0 | 545,430 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-05 4:08 pm |
N/A N/A |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
40,000 | $0 | 545,430 (Direct) |
View |
| 2022-08-03 Exercise |
2022-08-05 4:16 pm |
N/A N/A |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
98,666 | $0 | 665,430 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 4:06 pm |
N/A N/A |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
40,000 | $0 | 129,333 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:10 pm |
N/A N/A |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
15,100 | $0.4 | 416,097 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-26 4:10 pm |
N/A N/A |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
40,000 | $0.151 | 416,097 (Direct) |
View |
| 2021-02-24 Exercise |
2021-02-26 4:10 pm |
2019-12-11 2023-12-11 |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
40,000 | $0 | 416,097 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 4:10 pm |
N/A N/A |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
19,514 | $0.21 | 609,861 (Direct) |
View |
| 2021-01-04 Exercise |
2021-01-06 4:10 pm |
N/A N/A |
ACURA PHARMACEUTICALS INC | ACUR | CLEMENS PETER A Senior VP & CFO |
98,668 | $0 | 609,861 (Direct) |
View |